Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Apr 5, 2013 (14 years ago)

Glenmark Gabapentin Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Chemical Contamination: Gabapentin Sodium tablets is recalled due to complaints related to an off - odor described as moldy, musty or fishy in nature.

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

Glenmark Gabapentin Tablets, a) 600mg, 500- count bottle (NDC 68462-126-05), b) 800 mg, 500- count bottle (NDC 68462-127-05), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India, Manufactured for : Glenmark Generics USA Mahwah, NJ 07430.

Affected NDCs 68462-0126-05 68462-0127-05

Compare with the code on your package — it is the most precise check available.

Drug: Gabapentin Category: Pain Relief & OTC Medication

Product details

From the FDA NDC directory, for the product codes this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Gabapentin
NDC 68462-0126
600 mg/1 Tablet
Oral
Glenmark Pharmaceuticals Inc., USA Rx
Gabapentin
NDC 68462-0127
800 mg/1 Tablet
Oral
Glenmark Pharmaceuticals Inc., USA Rx
Recalling firm
Glenmark Generics Inc., USA
NDC code
68462-126-05
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-329-2013 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Gabapentin recalls

See all
Class II · Moderate risk

Gabapentin Capsules

Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

Ongoing Impurity / degradation The Harvard Drug Group LLC NDC 0904-6665-61 D-0031-2026
Class II · Moderate risk

Gabapentin Capsules

Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

Ongoing Impurity / degradation The Harvard Drug Group LLC NDC 0904-6665-61 D-0030-2026
Class II · Moderate risk

Gabapentin Capsules

Defective container; blister packaging inadequately sealed.

Ongoing Packaging defect The Harvard Drug Group LLC NDC 55154-3363-0 D-0508-2025
Class II · Moderate risk

Gabapentin Capsules

Defective container; blister packaging inadequately sealed.

Ongoing Packaging defect The Harvard Drug Group LLC NDC 0904-6665-61 D-0507-2025

Other recalls by Glenmark Generics Inc., USA

All 2013 recalls
Class II · Moderate risk

Ranitidine Tablets USP

Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign material", identified as Metoprolol Tartrate Tablet USP 50 mg, found co-mingled in a bottle of Ranitidine Tablets USP 150 mg.

Terminated Particulate / foreign matter Glenmark Generics Inc., USA NDC 68462-248-05 D-1229-2014
Class III · Low risk

Glenmark Topiramate Tablets

Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.

Terminated Chemical / undeclared Glenmark Generics Inc., USA NDC 68462-110-60 D-331-2013
Class III · Low risk

Glenmark Pravastatin Sodium Tablets

Chemical Contamination: Pravastatin Sodium Tablets isbeing recalled due to complaints related to an off-odor described as moldy, musty or fishy in nature.

Terminated Chemical / undeclared Glenmark Generics Inc., USA NDC 68462-197-90 D-330-2013
Class III · Low risk

Montelukast Sodium Tablets

Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA).

Terminated Chemical / undeclared Glenmark Generics Inc., USA NDC 68462-392-30 D-182-2013